Cargando…

The Use and Safety of TNF Inhibitors during Pregnancy in Women with Psoriasis: A Review

Psoriasis is a chronic immune-mediated inflammatory disease affecting women of childbearing potential. Biologic agents, notably Tumor Necrosis Factor inhibitors (TNFi), are the only current non-contraindicated systemic treatment option during pregnancy. TNFi comprised of complete immunoglobulin G (I...

Descripción completa

Detalles Bibliográficos
Autores principales:	Johansen, Cæcilie Bachdal, Jimenez-Solem, Espen, Haerskjold, Ann, Sand, Freja Lærke, Thomsen, Simon Francis
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2018
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5983707/ https://www.ncbi.nlm.nih.gov/pubmed/29751529 http://dx.doi.org/10.3390/ijms19051349

Ejemplares similares

Psoriasis and adverse pregnancy outcomes: A nationwide case-control study in 491,274 women in Denmark
por: Johansen, Cæcilie Bachdal, et al.
Publicado: (2022)

Comorbidities, socioeconomic status, drug use, and health care consumption in Danish women with psoriasis: A nationwide cross-sectional study
por: Johansen, Cæcilie Bachdal, et al.
Publicado: (2020)

TNF-Alpha Inhibitors for Chronic Urticaria: Experience in 20 Patients
por: Sand, Freja Lærke, et al.
Publicado: (2013)

Dermatological Diseases Associated with Pregnancy: Pemphigoid Gestationis, Polymorphic Eruption of Pregnancy, Intrahepatic Cholestasis of Pregnancy, and Atopic Eruption of Pregnancy
por: Sävervall, Christine, et al.
Publicado: (2015)

Use of anti-TNFs for difficult-to-treat urticaria: response to Cooke et al
por: Thomsen, Simon Francis, et al.
Publicado: (2015)

Clinician's Update on the Benign, Premalignant, and Malignant Skin Tumours of the Vulva: The Dermatologist's View
por: Sand, Freja Lærke, et al.
Publicado: (2017)

Pemphigoid gestationis: current perspectives
por: Sävervall, Christine, et al.
Publicado: (2017)

Mild-to-moderate severity of psoriasis may be assessed remotely based on photographs and self-reported extent of skin involvement
por: Ali, Zarqa, et al.
Publicado: (2023)

Asthma severity and fertility outcome in women with polycystic ovary syndrome: a registry-based study
por: Zierau, Louise, et al.
Publicado: (2018)

Maternal Characteristics of Women Exposed to Hypnotic Benzodiazepine Receptor Agonist during Pregnancy
por: Askaa, Bjarke, et al.
Publicado: (2014)

Safety of TNF-α inhibitors during IBD pregnancy: a systematic review
por: Nielsen, Ole Haagen, et al.
Publicado: (2013)

The role of TNF inhibitors in psoriasis therapy: new implications for associated comorbidities
por: Yost, John, et al.
Publicado: (2009)

Drug survival of ixekizumab, TNF inhibitors, and other IL‐17 inhibitors in real‐world patients with psoriasis: The Corrona Psoriasis Registry
por: Lockshin, Benjamin, et al.
Publicado: (2021)

Poor pregnancy outcome after octreotide treatment during pregnancy for familial hyperinsulinemic hypoglycemia: a case report
por: Skajaa, Gitte O, et al.
Publicado: (2014)

Safety of TNF inhibitors in adolescents and children
por: McCluggage, Lauren Keyser
Publicado: (2010)

Type 2 diabetes and psoriasis: links and risks
por: Holm, Jesper Grønlund, et al.
Publicado: (2019)

Duloxetine Exposure During Pregnancy and the Risk of Offspring Being Born Small for Gestational Age or Prematurely: A Nationwide Danish and Swedish Safety Study
por: Ankarfeldt, Mikkel Zöllner, et al.
Publicado: (2022)

Response: Letter regarding “The prognostic value of p16 and p53 expression for survival after vulvar cancer: A systematic review and meta-analysis”
por: Sand, Freja Lærke, et al.
Publicado: (2019)

Update on biologic safety for patients with psoriasis during pregnancy
por: Porter, Martina L., et al.
Publicado: (2017)

Awareness and Expectations Surrounding Family Planning and Pregnancy Among Danish Patients with Chronic Inflammatory Disease of the Skin or Joints: Results from an Online Survey
por: Johansen, Cæcilie B., et al.
Publicado: (2021)

Skin Mycobiome of Psoriasis Patients is Retained during Treatment with TNF and IL-17 Inhibitors
por: Koike, Yuta, et al.
Publicado: (2020)

IL-17A and TNF-α inhibitors induce multiple molecular changes in psoriasis
por: Dong, Qiang, et al.
Publicado: (2022)

β-Blocker treatment during pregnancy and adverse pregnancy outcomes: a nationwide population-based cohort study
por: Meidahl Petersen, Kasper, et al.
Publicado: (2012)

Pregnancy Outcomes in the Tofacitinib Safety Databases for Rheumatoid Arthritis and Psoriasis
por: Clowse, Megan E. B., et al.
Publicado: (2016)

Comparison of the risk of heart failure in psoriasis patients using anti‐TNF α inhibitors and ustekinumab
por: Han, Ju Hee, et al.
Publicado: (2022)

Recurrence of psoriasis on the resolution sites left with lentiginous pigmented patches after TNF inhibitor therapy()
por: Yamamoto, Toshiyuki
Publicado: (2023)

Analysing cord blood levels of TNF inhibitors to validate the EULAR points to consider for TNF inhibitor use during pregnancy
por: Ghalandari, Nafise, et al.
Publicado: (2022)

Prevalence of Antidepressant Use during Pregnancy in Denmark, a Nation-Wide Cohort Study
por: Jimenez-Solem, Espen, et al.
Publicado: (2013)

Anti-TNF-Alpha-Induced Psoriasis – An Unusual Paradox
por: Sharma, Neel, et al.
Publicado: (2009)

Case Report: TNF-Alpha Inhibitors to Rescue Pregnancy in Women With Potential Pregnancy Loss: A Report of Ten Cases
por: Zhong, Zixing, et al.
Publicado: (2022)

JAK Inhibitors: Treatment Efficacy and Safety Profile in Patients with Psoriasis
por: Hsu, Leeyen, et al.
Publicado: (2014)

Effectiveness and safety of TNF inhibitors in adults with juvenile idiopathic arthritis
por: Kearsley-Fleet, Lianne, et al.
Publicado: (2016)

Clarithromycin in Early Pregnancy and the Risk of Miscarriage and Malformation: A Register Based Nationwide Cohort Study
por: Andersen, Jon Trærup, et al.
Publicado: (2013)

Th1, Th17, and Treg Responses are Differently Modulated by TNF-α Inhibitors and Methotrexate in Psoriasis Patients
por: Furiati, Sandro C., et al.
Publicado: (2019)

The Effect of TNF-α Inhibitors on Nail Psoriasis and Psoriatic Arthritis—Real-World Data from Dermatology Practice
por: Kokolakis, Georgios, et al.
Publicado: (2021)

Exposure to duloxetine during pregnancy and risk of congenital malformations and stillbirth: A nationwide cohort study in Denmark and Sweden
por: Ankarfeldt, Mikkel Zöllner, et al.
Publicado: (2021)

Omalizumab for Chronic Urticaria: A Case Series and Overview of the Literature
por: Ivyanskiy, Ilya, et al.
Publicado: (2012)

Use of palivizumab is underestimated in the Swedish Prescribed Drug Register – implications for register-based drug studies
por: Linder, Marie, et al.
Publicado: (2014)

Duloxetine Exposure During Pregnancy and the Risk of Spontaneous and Elective Abortion: A Danish Nationwide Observational Study
por: Ankarfeldt, Mikkel Zöllner, et al.
Publicado: (2021)

Safety of selective IL‐23p19 inhibitors for the treatment of psoriasis
por: Crowley, J.J., et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_rukju6iiktp91rfe1lftvu6let